[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"condbio:chronic-myelomonocytic-leukemia:hla-complex":3},{"condition":4,"biomarker":5,"total":6,"trials":7},"Chronic Myelomonocytic Leukemia","HLA Complex",6,[8,16,22,29,35,41],{"nct_id":9,"title":10,"phases":11,"status":13,"updated_at":14,"content_modified":15},"NCT07582172","Total Marrow and Lymphoid Irradiation in Combination With Fludarabine and Melphalan as Conditioning for Allogeneic Peripheral Blood Stem Cell Hematopoietic Cell Transplant in Older Patients With Refractory and Relapsed Acute Myeloid Leukemia and High-risk Myelodysplastic Syndrome",[12],"Phase 2","RECRUITING","2026-08-26T02:19:17.380174Z","2026-05-13T02:55:06.792892Z",{"nct_id":17,"title":18,"phases":19,"status":13,"updated_at":20,"content_modified":21},"NCT07046078","Combination Chemotherapy (FLAG-Ida) Followed Immediately by Reduced-Intensity Total Body Radiation Therapy and Donor Hematopoietic Cell Transplant for the Treatment of Adults Age 60 and Older With Newly Diagnosed Adverse-Risk Acute Myeloid Leukemia or Other High-Grade Myeloid Cancer",[12],"2026-08-26T02:19:25.538428Z","2026-05-05T02:35:31.876787Z",{"nct_id":23,"title":24,"phases":25,"status":13,"updated_at":27,"content_modified":28},"NCT05470491","Trial of Allogeneic Reduced-Intensity, HLA-Haploidentical Allogeneic Hematopoietic Cell Bone Marrow Transplantation Followed by Graft-versus-Host-Disease (GVHD) Prophylaxis With Cyclophosphamide, Bortezomib and Maraviroc for Hematologic Malignancies ...",[26],"Phase 1\u002FPhase 2","2026-08-26T02:17:35.666428Z","2026-05-05T02:43:29.587324Z",{"nct_id":30,"title":31,"phases":32,"status":13,"updated_at":33,"content_modified":34},"NCT05031897","Two Step Haplo With Radiation Conditioning",[12],"2026-08-26T02:16:32.589113Z","2026-05-05T02:43:29.158573Z",{"nct_id":36,"title":37,"phases":38,"status":13,"updated_at":39,"content_modified":40},"NCT06680661","ABBA CORD: dCBT w\u002F Abatacept for aGVHD Prophylaxis",[12],"2026-08-26T02:17:14.343713Z","2026-05-05T02:43:28.824003Z",{"nct_id":42,"title":43,"phases":44,"status":13,"updated_at":46,"content_modified":47},"NCT06904066","Autologous T Cells Transduced With Retroviral Vectors Expressing TCRs for Participant-specific Neoantigens in Patients With Hematologic Malignancies",[45],"Phase 1","2026-08-26T02:18:59.761994Z","2026-05-05T02:43:27.428326Z"]